V. Anandan et al. 2022. Cyclosporine – in the Management of Severe Cutaneous Adverse Drug Reactions. Current Overview on Disease and Health Research Vol. 2. (Jul. 2022), 114–127. DOI:https://doi.org/10.9734/bpi/codhr/v2/16680D.